Cite
Bashier A, Khalifa AA, Rashid F, et al. Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes. J Clin Med Res. 2017;9(6):499-507doi: 10.14740/jocmr2976w.
Bashier, A., Khalifa, A. A., Rashid, F., Abdelgadir, E. I., Al Qaysi, A. A., Ali, R., Eltinay, A., Nafach, J., Alsayyah, F., & Alawadi, F. (2017). Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes. Journal of clinical medicine research, 9(6), 499-507. https://doi.org/10.14740/jocmr2976w
Bashier, Alaaeldin, et al. "Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes." Journal of clinical medicine research vol. 9,6 (2017): 499-507. doi: https://doi.org/10.14740/jocmr2976w
Bashier A, Khalifa AA, Rashid F, Abdelgadir EI, Al Qaysi AA, Ali R, Eltinay A, Nafach J, Alsayyah F, Alawadi F. Efficacy and Safety of SGLT2 Inhibitors in Reducing Glycated Hemoglobin and Weight in Emirati Patients With Type 2 Diabetes. J Clin Med Res. 2017 Jun;9(6):499-507. doi: 10.14740/jocmr2976w. Epub 2017 Apr 26. PMID: 28496550; PMCID: PMC5412523.
Copy
Download .nbib